What is Known:
• Children with juvenile localized scleroderma (jLS) are managed by a number of specialties including pediatric rheumatologists and dermatologists, sometimes in shared clinics. Studies have shown that management varies considerably and that there are notable differences between specialties .
• There is very little published guidance on management of jLS.
What is new:
• These recommendations aim to standardize diagnosis, assessment, and management through review of pediatric evidence and consensus agreement.
• Joint review of patients by both pediatric rheumatologists and dermatologists is recommended.